RxDoctor Payments Data

Tanya Bernal

Psychiatric/Mental Health · Sandusky, OHNPI 1184953259

Payments from drug & device makers

$3,417in general payments, 2019–2025

Across 184 payments — averaging $18.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$599
  • Teva Pharmaceuticals USA, Inc.$538
  • Johnson & Johnson$468
  • Alkermes, Inc.$419
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$392
  • Otsuka America Pharmaceutical, Inc.$314
  • plus $687 from 9 others

What the payments were for

  • Food & beverage$3,06790%
  • Education$35110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,417 in reported general payments places this provider in the 85th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate115$391,434
HetliozTasimelteon15$350,990
IngrezzaValbenazine Tosylate27$217,111
Austedo XrDeutetrabenazine17$182,512
Invega TrinzaPaliperidone Palmitate18$176,769
AustedoDeutetrabenazine21$135,384
RexultiBrexpiprazole83$123,749
VraylarCariprazine Hcl71$118,534
Abilify MaintenaAripiprazole29$86,332
Risperdal ConstaRisperidone Microspheres20$48,829
FanaptIloperidone14$33,195
TrintellixVortioxetine Hydrobromide43$31,865
CaplytaLumateperone Tosylate13$20,830
LybalviOlanzapine/Samidorphan Malate13$20,084
Aripiprazole213$19,225

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza, Risperdal Consta$468$617,032153 claims
Vanda Pharmaceuticals Inc.Hetlioz, Fanapt$42$384,18529 claims
Teva Pharmaceuticals USA, Inc.Austedo Xr, Austedo$538$317,89738 claims
Neurocrine Biosciences, Inc.Ingrezza$48$217,11127 claims
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$314$210,081112 claims
AbbVieVraylar, Saphris$599$132,35183 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$25$31,86543 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$392$20,83013 claims
Alkermes, Inc.Lybalvi$419$20,08413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Sandusky

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →